new post
StocksRunner logo
mail
search
 
menu
 
Pfizer
$25.52
-0.51%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

PFE Stock Analysis & IQ Rating | Pfizer

 
 

PFE

 

Pfizer

$25.52

 
-$0.13 | -0.51%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$27.69
 
 
MKT CAP
$145.10B
 
52W Low
$20.92
 
 
VOL
$51.67M
 
P/E Ratio
14.83
 
 
AVG VOL
$47.32M
 
RSI
52.94
 
 
TREND
Uptrend
 
 
 

PFE Stock IQ

 
lock  Login to see Pfizer (PFE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

PFE Target Price

 
 
 

Strengths

 
 

PFE Rewards

 Earnings are forecast to grow

PFE Rewards

 Trading below its fair value

PFE Rewards

 Upgraded on attractively valued

PFE Rewards

 Investors confidence is positive

 
 

PFE Price Performance

 
 

$25.21   (+1.23%)

$24.76   (+3.07%)

$25.07   (+1.79%)

$26.44   (-3.48%)

 
 
1year
6month
3month
1month
 

PFE Analysts Opinion

 

PFE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

PFE Earnings Sentiment

 Above analyst estimates

PFE Earnings Sentiment

 Earnings decline YoY

PFE Earnings Sentiment

 Reported a strong earnings

PFE Earnings Sentiment

 Revenue increase YoY

 
 

Rating

×
 

Rating

 

PFE Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

PFE Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

 

PFE Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

PFE Future Sentiment

 Earnings are forecast to grow

PFE Future Sentiment

 Trading below its fair value

PFE Future Sentiment

 Outperform the market

 
 

PFE Analysts Opinion

PFE Analysts opinion is positive but there was a setback from the past 3 months

 

PFE Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
71%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
0%
50%
82%
 

PFE Street Sentiment 

PFE Street Sentiment is bullish and have positive views on the near-term outlook

 

PFE Risk Level

 
 

PFE has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 
 
PFE Risk Level
Low
LOW
HIGH
 

PFE Performance Sentiment

 
Sentiments overview associated with PFE events and the stock performance.
 
 
71%
20%
Positive
Negative
32 out of 45
events present
9 out of 45
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$25.52
 
Resistance
Price
 
$24.88
 
 
Current Price Range
 
$25.89
 
 
Show methods +
 
 
PFE Latest Analysis +
 
 
FAQ About PFE Stock Insights
 

What is PFE current stock price?

What are PFE stock strengths?

What is PFE Risk Level?

What is PFE market cap and volume?

What is PFE current Stock IQ?

Should I buy PFE stock right now?

Is PFE a Strong Buy right now?

What does a 'Strong Buy' rating mean for PFE?

What does a 'Strong Sell' rating mean for PFE?

What factors influence PFE's Stock IQ?

 
 
StocksRunner

Explore our PFE Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored PFE Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our PFE Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 
 

PFE

 

Pfizer

 
Set Alerts
 
 

Current Price

 

$25.52

 
-$0.13 | -0.51%
 
 
52W High
$27.69
 
 
MKT CAP
$145.10B
 
52W Low
$20.92
 
 
VOL
$51.67M
 
P/E Ratio
14.83
 
 
AVG VOL
$47.32M
 
RSI
52.94
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

PFE Rewards

 Earnings are forecast to grow

PFE Rewards

 Trading below its fair value

PFE Rewards

 Upgraded on attractively valued

PFE Rewards

 Investors confidence is positive

 
 
 
 
user
 
 
 
 

PFE Price Performance

 
 

$25.21   (+1.23%)

$24.76   (+3.07%)

$25.07   (+1.79%)

$26.44   (-3.48%)

 
 
1year
6month
3month
1month
 

PFE Analysts Opinion

 

PFE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

PFE Earnings Sentiment

 Above analyst estimates

PFE Earnings Sentiment

 Earnings decline YoY

PFE Earnings Sentiment

 Reported a strong earnings

PFE Earnings Sentiment

 Revenue increase YoY

 
 

Rating

×
 

Rating

 

PFE Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

PFE Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

 

PFE Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

PFE Future Sentiment

 Earnings are forecast to grow

PFE Future Sentiment

 Trading below its fair value

PFE Future Sentiment

 Outperform the market

 
 

PFE Analysts Opinion

PFE Analysts opinion is positive but there was a setback from the past 3 months

 

PFE Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
71%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
0%
50%
82%
 

PFE Street Sentiment 

PFE Street Sentiment is bullish and have positive views on the near-term outlook

 

PFE Risk Level

 
 

PFE has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 
 
PFE Risk Level
Low
LOW
HIGH
 
PFE Performance Sentiment
 
Sentiments overview associated with PFE events and the stock performance.
 
 
71%
20%
Positive
Negative
32 out of 45
events present
9 out of 45
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$25.52
 
Resistance
Price
 
$24.88
 
 
Current Price Range
 
$25.89
 
 
Show methods +
 
 

Latest Analysts Recommendations

 
 
Date
Action
Rating
Firm

 

Jan 16, 2026

Initiate

Neutral

UBS

 

Jan 12, 2026

Initiate

Neutral

UBS

 

Dec 30, 2025

Reiterate

Buy

Scotiabank

 

Dec 22, 2025

Downgrade

Hold

 

Dec 17, 2025

Reiterate

Buy

Guggenheim

 

 
 
 
 
 

PFE Stock IQ

 
 
 
lock  Login to unlock Pfizer (PFE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

PFE Latest Analysis

 
 
 

Novavax Licenses Matrix-M Adjuvant To Pfizer For Upfront Payment Of $30 Mln . (RTTNews) - Novavax Inc. (NVAX) announced Tuesday that it has entered into a license agreement with Pfizer Inc. (PFE) for use of Novavaxs Matrix-M adjuvant. Under the terms of the agreement Pfizer will obtain a non-exclusive license for Matrix-M for use with Pfizers products

 

Tue Jan 20, 2026

$25.52 | -0.51%
 
Activity

Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science. Abcam has joined an industry-academic partnership led by the Structural Genomics Consortium and Pfizer to advance AI-driven drug discovery through open science a new public-private partnership with a budget of more than €60 million. Through this collaboration the Innovative Health Initiative Project LIGAND-AI will generate large high-quality protein–l

 

Tue Jan 20, 2026

$25.52 | -0.51%
 
Activity
Potential

Pfizer exits GSK majority-owned ViiV Healthcare. Shionogi raises stake.

 

Tue Jan 20, 2026

$25.52 | -0.51%
 
Activity

Pfizer (PFE) CEO Isnt Ready For A Fight With RFK Jr. Says Jim Cramer. We recently published 10 Stocks Jim Cramer Talked About.  Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer talked about. Pharma giant Pfizer Inc. (NYSE:PFE)s shares are down by 4.7% over the past year and flat year-to-date. UBS initiated coverage of the stock in January as it set a Neutral rating for the [….]

 

Fri Jan 16, 2026

$25.65 | -0.93%
 
Momentum
Rating

Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30. Pfizer Inc. (NYSE:PFE) is one of the best affordable stocks under $30. Pfizer Inc. (NYSE:PFE) announced on January 10 positive results from Cohort 3 which is a separate randomized cohort of the pivotal BREAKWATER trial evaluating BRAFTOVI® in combination with cetuximab and FOLFIRI in patients with previously untreated metastatic colorectal cancer with a BRAF V600E [….]

 

Thu Jan 15, 2026

$25.89 | +1.21%
 
Potential

PFE Market Cap Falls More Than $7B in a Month: How to Play the Stock. Pfizer shares fall nearly 5% in a month after weak 2026 guidance sparking debate over buying the dip or staying cautious.

 

Wed Jan 14, 2026

$25.58 | +1.71%
 
Momentum
Momentum
Potential

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra.

 

Mon Jan 12, 2026

$25.27 | -0.79%
 
Momentum

UBS Likes Pfizers MTSR Obesity Deal but Stays Neutral on PFE. Pfizer Inc. (NYSE:PFE) is included among the 13 Best Dividend Stocks Paying Over 6%. On January 7 UBS initiated coverage of Pfizer Inc. (NYSE:PFE) with a Neutral rating and a $25 price target. The firm pointed to lingering uncertainty around Pfizers revenue outlook with roughly $15 billion to $20 billion tied to major drugs expected [….]

 

Mon Jan 12, 2026

$25.27 | -0.79%
 
Potential
Rating

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

 

Mon Jan 12, 2026

$25.27 | -0.79%
 
Activity

Pfizer inks licensing deal with Madrigal for MASH candidate.

 

Fri Jan 9, 2026

$25.48 | +0.75%
 
Activity

 
 
 
 
 
StocksRunner

Discover PFE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of PFE. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our PFE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

PFE Stock trends

PFE Stock performance

PFE Stock analysis

PFE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

PFE Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
Cancel
 
×
 
0/666
joker
 
Post
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing PFE

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing PFE

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.